Here are Wednesday's biggest analyst calls: SpaceX, AMD, Apple, Adobe, CoreWeave & more

Wall Street analysts issued a broad mix of upgrades, downgrades and reiterated ratings, with no reported share-price reactions. Morgan Stanley cut Flagstar’s price target from $15 to $12 and downgraded it to Underweight, while Citi downgraded Adobe to Sell on downside risk to FY27 growth estimates. Positive calls included Guggenheim’s Lockheed Martin Buy rating with a $735 target (15% upside) and Cantor Fitzgerald’s Ouster upgrade to Overweight after shares fell about 55% from their 52-week high.

Analysis

This is a broker-revision tape, not a common macro signal: the mixed aggregate sentiment argues against buying the list indiscriminately. Near term, price action may follow estimate changes, but the more durable distinction is between businesses with operating evidence and stories dependent on multiple support or financing. NVTS’s reported backlog/book-to-bill and ALAB’s raised guidance are more testable than an analyst’s valuation-floor argument; verify conversion, customer concentration, and guidance quality before treating either as a trend. For CRWV, financing terms are the key equity variable: higher funding costs can absorb operating progress and constrain growth, while a credible funding package could rapidly unwind the discount. A relative-value expression within AI infrastructure is therefore more defensible than an outright sector call, though it remains exposed to a broad capex slowdown.

Over 1–3 months, ADBE’s downgrade matters only if estimates actually reset; watch guidance and evidence that product demand or monetization is deteriorating rather than infer a specific cause from the broker note. CPNG’s prospective margin improvement also needs confirmation in reported sequential EBITDA, not just a GMV-based floor valuation. Over 6–18 months, infrastructure replacement and defense demand may support CNM and LMT, but procurement timing and valuation can still dominate returns. Contrarian point: a long list of upgrades can look like broad improving fundamentals, but several calls rely on prospective catalysts or valuation claims. Treat analyst ratings as prompts for verification, not independent catalysts.

Key Decisions for Investors

• Consider a small, beta-aware long AMD / short CRWV relative-value position to express preference for semiconductor exposure over a financing-sensitive compute intermediary. Add only after reviewing CRWV’s debt, maturities, committed funding, and customer concentration; reduce the short if funding is secured on manageable terms. Falsify the thesis if AMD guidance weakens while CRWV demonstrates durable financing and improving unit economics.
• Keep ADBE on a conditional short/watch list rather than shorting solely on the downgrade. Require evidence of estimate cuts or weaker forward guidance; cover or avoid the trade if growth expectations stabilize and the next report supports monetization. The missing data are the specific negative catalysts and the size of any consensus reset.
• For NVTS and ALAB, prefer confirmation over chasing the analyst reaction: track backlog conversion, customer concentration, and subsequent guidance over the next 1–2 quarters. A decelerating book-to-bill, delayed shipments, or guidance reversal would invalidate the bullish setup.
• No broad trade from the roundup. Monitor CPNG’s reported sequential adjusted EBITDA and offering-related losses, and CNM’s order/backlog and municipal replacement demand; initiate only if operating results validate the thesis rather than relying on valuation-floor or long-term-demand claims.